Privacy Notice, Terms of Use & Clinical Basis

Yellow Baby Newborn Bilirubin Chart (neonatalhyperbilirubinemia.org) | Operated by Alpha Centauri Technologies Inc. | Last updated: October 28, 2026

1. Privacy, URL-Fragment Handling & De-Identified Research Logging

The Yellow Baby Newborn Bilirubin Chart is designed to protect patient and user privacy while supporting neonatal hyperbilirubinemia research and quality improvement:

2. Clinical Basis, Scope & Non-Device CDS Transparency

Scope Restriction (≥35 Weeks' Gestation Only): This reference tool applies only to newborn infants born at 35 or more completed weeks of gestation (postnatal age 0 to 336 hours / 14 days for AAP 2022 curves; 0 to 168 hours / 7 days for legacy 1999/2004 nomograms). It must not be used for preterm infants under 35 weeks of gestational age.

In accordance with 21 U.S.C. section 360j(o)(1)(E) (FD&C Act section 520(o)(1)(E), Non-Device Clinical Decision Support Criterion 4), the underlying peer-reviewed clinical practice guidelines and calculation methods are disclosed below so that health care professionals can independently review and verify the basis for every plotted point and threshold:

3. Medical Disclaimer & Terms of Use

For clinical reference and educational discussion with your baby's doctor only - not medical advice. This website does not provide medical advice, clinical diagnosis, or treatment recommendations, and use of this website does not create a physician-patient relationship.

4. Operator, Ownership & Contact Information

The Yellow Baby Newborn Bilirubin Chart (neonatalhyperbilirubinemia.org) and its software, design, and content are owned and operated by Alpha Centauri Technologies Inc., a Delaware corporation.

← Back to Newborn Bilirubin Chart